Join the Non-Small Cell Lung Cancer group to help and get support from people like you.
Non-Small Cell Lung Cancer News (Page 4)
Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC
Alternative Explanation Conditions Often Delay Lung Cancer Diagnosis
WEDNESDAY, Sept. 11, 2024 – Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals, according to a study published online Aug. 23 in...
Lung Complications + Rheumatoid Arthritis Increase Risk for Lung Cancer
FRIDAY, Sept. 6, 2024 – The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study published online Sept. 3 in Modern Rheumatology. ...
Radiotherapy Dose to Cardiac Substructures Linked to Arrhythmias
TUESDAY, Aug. 27, 2024 – For patients with locally advanced non-small cell lung cancer, radiotherapy dose to discrete cardiac substructures is associated with pathophysiologically distinct...
Alternative Criteria Can ID High-Benefit Groups for Lung Cancer Screening
MONDAY, Aug. 19, 2024 – Simple alternative criteria for lung cancer screening (LCS) can identify high-benefit groups, especially among certain racial and ethnic-minority groups, according to a study...
Imfinzi Approved in the US for the Treatment of Resectable Non-Small Cell Lung Cancer Before and After Surgery
16 August 2024 – AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved in the US for the treatment of adult patients with resectable early-stage (IIA-IIIB) non-small c...
Many Nonsmokers Have Lung Nodules Linked to Cancer Risk
TUESDAY, Aug. 13, 2024 – Many nonsmokers have lung nodules that have been linked to lung cancer, a new study warns. About 42% of nonsmokers or former smokers have at least one lung nodule, which is...
Rheumatoid Arthritis Tied to Higher Risk for Lung Cancer
FRIDAY, Aug. 9, 2024 – Rheumatoid arthritis (RA) is associated with a significantly increased risk for lung cancer, according to a study published online July 28 in Arthritis & Rheumatology. Rebecca ...
Smoking & Vaping Together Raise Lung Cancer Risks Even Higher
FRIDAY, Aug. 2, 2024 – Experts have long suspected it, but a new study confirms that folks who vape and smoke tobacco face higher risks for lung cancer than if they'd done either alone. “From a p...
E-Cigarette Use Linked to Lower Use of Lung Cancer Screening
TUESDAY, July 9, 2024 – Electronic cigarette use is associated with a lower use of lung cancer screening (LCS), according to a research letter published online July 2 in JAMA Network Open. Qian...
Intensity-Modulated Radiotherapy Recommended for Locally Advanced Lung Cancer
TUESDAY, July 9, 2024 – Intensity-modulated radiotherapy (IMRT) is recommended for locally advanced non-small cell lung cancer (NSCLC) and appears to have good long-term outcomes, according to a...
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
South San Francisco, CA – April 18, 2024 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Rybrevant (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
RARITAN, New Jersey (March 01, 2024) – Johnson & Johnson (NYSE: JNJ) announced today that following a priority review, the U.S. Food and Drug Administration (FDA) has approved Rybrevant® (a...
Tagrisso With the Addition of Chemotherapy Approved in the US for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
19 February 2024 – AstraZeneca’s Tagrisso has been approved in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) n...
FDA Grants Traditional Approval to Tepmetko (tepotinib) for Metastatic Non-Small Cell Lung Cancer
On February 15, 2024, the Food and Drug Administration granted traditional approval to tepotinib (Tepmetko, EMD Serono, Inc.) for adult patients with metastatic non-small cell lung cancer (NSCLC)...
FDA Approves Augtyro (repotrectinib) for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Augtyro (repotrectinib) for the treatment of adult...